glp 1 drugs and ulcerative colitis Today's the day. 🔬✨ From GLP-1s real-world outcomes to engineered biotherapeutics designed for the inflamed colon — and new data on durable remission in #UlcerativeColitis care — #CCCongress26 is bringing the GLP-1 Receptor Agonists in Obese

Cardiovascular risk reduction Jardiance is FDA-approved to reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease, as well as adults with heart failure and reduced ejection fraction

It is primarily used as subcutaneous injections and oral formulations [6,7]

Hormones, metabolism, and underlying health conditions can make it difficult to lose weight and keep it off

This would widen their access and possibly lower their prices and open the door to tackling the problem of loss of muscle mass.

The average calorie intake was 1,748 kcal/d, which exceeds the average 1,500 kcal/d goal

Limiting these foods particularly in the early weeks can make a meaningful difference in how you feel day to day